REAL LIFE DATA FROM THE FIRST LINE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL CENTER

被引：0
|
作者：
Sanchez-Raga, J. M. [1 ]
Perez-Montana, A. [1 ]
Beltran, N. [1 ]
Ros, T. [1 ]
Boyeras, B. [1 ]
Martorell, C. [1 ]
Gutierrez, A. [1 ]
Sampol, A. [1 ]
机构：
[1] Hosp Univ Son Espases, Palma De Mallorca, Spain
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-008
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [21] MULTIPLE MYELOMA MAINTENANCE TREATMENT IN REAL-LIFE PATIENTS
    Rafael, Rios-Tamayo
    Dolores, Sanchez-Rodriguez
    Carolina, Alarcon
    Jose Manuel, Puerta
    Amanda, Nunez
    Juan, Sainz
    Pilar, Garrido
    Almudena, Garcia
    Ana Beatriz, Rivera
    Dolores, Fernandez
    Francisca, Hernandez
    Manuel, Jurado
    HAEMATOLOGICA, 2016, 101 : 97 - 98
  • [22] Real world results of multiple myeloma patients - low mortality rate from first-line to second-line treatment
    Keil, F.
    Attalla, P.
    Seebacher, A.
    Burger, S.
    Koller, E.
    Sliwa, T.
    Laschan, C.
    Krauter, A.
    Pfeilstoecker, M.
    List, A.
    Fillitz, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 180 - 181
  • [23] THE MAINTENANCE TREATMENT AS A THERAPEUTIC STRATEGY IN PATIENTS WITH MULTIPLE MYELOMA EXPERIENCE OF A CENTER
    Garcia Feria, A.
    Carretero, V
    Ferrandis, P.
    Pacios, A.
    Mosquera, D. P.
    Picon, I
    HAEMATOLOGICA, 2017, 102 : 290 - 290
  • [24] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION AS FIRST LINE TREATMENT IN MULTIPLE MYELOMA. SINGLE CENTER EXPERIENCE
    Arguinano, J. M.
    Zudaire, M.
    Pena, E.
    Aoiz, I.
    Hamdi, M.
    Mateos, M.
    Ardaiz, M.
    Viguria, M.
    Rodriguez Calvillo, M.
    Gorosquieta, A.
    Sanchez Anton, M.
    Quispe, I.
    Arregui, P.
    Montoya, M.
    Garcia Ramirez, P.
    Alvarellos, M.
    HAEMATOLOGICA, 2015, 100 : 735 - 735
  • [25] First-line treatment of multiple myeloma
    Breitkreutz, I
    Raab, M.
    Goldschmidt, H.
    INTERNIST, 2019, 60 (01): : 23 - 33
  • [26] CLINICAL EXPERIENCE WITH FIRST-LINE VRD IN MULTIPLE MYELOMA DIAGNOSTIC PATIENTS
    De Miguel Llorente, D.
    Gil Perez, A.
    Diaz Morfa, M.
    Golbano Lopez, N.
    Vazquez Ramo, A.
    Guillen Lopez, H.
    Nuevo Lopez, I
    Perez Ortega, A.
    Arbeteta Juanis, J.
    Subira Perez, D.
    Morales Sanz, D.
    Garcia Ramirez, P.
    Santos Montero, A. B.
    Herrero Martin, S.
    HAEMATOLOGICA, 2019, 104 : 194 - 195
  • [27] CLINICAL EXPERIENCE WITH FIRST-LINE VRD IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA
    De Miguel, Llorente Dunia
    Gil, Perez Angela
    Merchan, Munoz Beatriz
    Nuevo, Lopez Irene
    Perez, Ortega Alba
    Guillen, Garcia Helga
    Vazquez, Ramo Alejandro
    Subira, Perez Dolores
    Golbano, Lopez Nuria
    Santos, Montero Ana Belen
    Morales, Sanz Dolores
    Arbeteta, Juanis Jaime
    HAEMATOLOGICA, 2020, 105 : 150 - 151
  • [28] Efficacy of Bortezomib as First-Line Treatment for Patients with Multiple Myeloma
    Painuly, Utkarsh
    Kumar, Shaji
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 53 - 73
  • [29] REAL-LIFE EXPERIENCE WITH POMALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Cubillas, Garcia de la Torre Damian
    Inigo, Rodriguez Belen
    Alfayate, Lobo Ana
    Menendez, Cuevas Marina
    Bolanos, Calderon Estefania
    Medina, Salazar Sissy Fiorella
    Mateo, Morales Marta
    Pena, Cortijo Ascension
    Perez, Lopez Cristina
    Polo, Zarzuela Marta
    Calo, Perez Aida
    Colas, Lahuerta Blanca
    Gomez, Alvarez Miguel
    Escribano, Serrat Silvia
    Estival, Monteliu Pablo
    Gulino, Horacio
    Daorta, Melisa
    Moreno, Paredes Nahir Daniela
    Benavente, Cuesta Celina
    HAEMATOLOGICA, 2020, 105 : 151 - 151
  • [30] REAL WORLD DATA ON MULTIPLE MYELOMA TREATMENT PATTERNS: FIRST AND SECOND-LINE TREATMENT IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Lemmer, T.
    Martins, R. E.
    Kashiura, D.
    Saad, R.
    VALUE IN HEALTH, 2017, 20 (09) : A879 - A879
12345